13 research outputs found

    Heavy-ion Results of the CMS Experiment

    No full text
    An overview of selected heavy-ion results of the CMS experiment is presented. Jet quenching, quarkonia suppression and two-particle angular correlation results are discussed. The measurements have been performed for lead–lead, proton–lead and proton–proton data samples recorded for Run 1 of the LHC accelerator. In the correlation analysis, low pile-up proton–proton collisions at an energy of 13 TeV (from Run 2) have been used as wel

    Flow-chart to achieve final study population.

    No full text
    <p>Conditions may overlap: excluded participants are not mutually exclusive. *Weight either < 30 Kg or > 300 Kg; <sup>^</sup>Height < 100 cm.</p

    Association between eating disorder subtypes and use of medication in the postpartum period<sup>†</sup>.

    No full text
    <p><sup>†</sup>Indicates medication use at any point in the period 0–6 months after delivery, irrespective of the medication use status before or during pregnancy. The RR is computed when there are at least 3 women exposed to the medication group of interest. Statistically significant results are in bold.</p><p>*Model 1: Adjustment done for maternal age (as continuous variable), socioeconomic status and educational level (for all medication groups).</p><p><sup>‡</sup>Model 2: Adjustment done for all covariates in Model 1 with addition of weight decrease six months after delivery and breastfeeding status, depressive and anxiety symptoms postpartum, and cesarean section (for analgesics).</p><p>Association between eating disorder subtypes and use of medication in the postpartum period<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0133045#t003fn001" target="_blank"><sup>†</sup></a>.</p

    Flow-chart to achieve final study population.

    No full text
    <p>Conditions may overlap: excluded participants are not mutually exclusive. *Weight either < 30 Kg or > 300 Kg; <sup>^</sup>Height < 100 cm.</p

    Use of psychotropic medications before, during, and after pregnancy by type of eating disorder<sup>†</sup>.

    No full text
    <p>Abbreviations: AN (anorexia nervosa), BN (bulimia nervosa), EDNOS-P (eating disorder not otherwise specified, purging type), BED (binge-eating disorder), ED (eating disorder). <sup>†</sup>Psychotropic medications include antidepressants, antipsychotics, anxiolytics and hypnotics and sedatives. *Indicates p-value ≤0.001; <sup>‡</sup>Indicates p-value ≤0.01.</p

    Measure of association between eating disorder subtypes and medication use during pregnancy<sup>†</sup>.

    No full text
    <p><sup>†</sup>Indicates medication use at any point during pregnancy, irrespective of the medication use status before or after pregnancy. The RR is computed when there are at least 3 women exposed to the medication group of interest. Statistically significant results are in bold.</p><p>*Model 1: Adjustment done for maternal age (as continuous variable), socioeconomic status and educational level (for all medication groups).</p><p><sup>‡</sup>Model 2: Adjustment done for all covariates in Model 1 with addition of alcohol use during pregnancy, smoking during pregnancy, weight gain during entire pregnancy (as continuous variable), BMI at conception (as continuous variable), depressive and anxiety symptoms throughout the pregnancy (as continuous variable), pain ailments in pregnancy (for analgesics), and gastrointestinal disorders during pregnancy (for gastrointestinal drugs).</p><p>Measure of association between eating disorder subtypes and medication use during pregnancy<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0133045#t002fn001" target="_blank"><sup>†</sup></a>.</p

    Maternal sociodemographics, morbidities and mental health across the eating disorder subtype (n = 62,019)<sup>†</sup>.

    No full text
    <p>Abbreviations: AN (anorexia nervosa), BN (bulimia nervosa), EDNOS-P (eating disorder not otherwise specified, purging type), BED (binge-eating disorder), ED (eating disorder); BMI (body mass index); NOK (Norwegian Kroners).</p><p><sup>a</sup>The BMI is the weight in kilograms divided by the square of the height in meters: underweight: <18.5 kg/m<sup>2</sup>; normal weight: 18.5–24.9 kg/m<sup>2</sup>; overweight: 25.0–29.9 kg/m<sup>2</sup>; obese≥30 kg/m<sup>2</sup>.</p><p><sup>b</sup>Primary or secondary education: <10 years (primary) or 10–12 years (secondary) of education; University degree or higher: college or university education.</p><p><sup>c</sup>Indicates smoking until gestational week 30.</p><p><sup>d</sup>Indicates alcohol use at the beginning of pregnancy, until gestational week 17.</p><p><sup>e</sup>Includes heartburn/reflux, duodenal/stomach ulcers, Crohn disease/ulcerative colitis and other gastrointestinal problems.</p><p><sup>f</sup>Indicates scoring over the cut-off point at both gestational weeks 17 (5-items Hopkins symptoms checklist SCL-5≥2) and 30 (8-items Hopkins symptoms checklist SCL8≥1.85).</p><p><sup>†</sup>Numbers may not add up to total because of missing values (<5%). For the variables “smoking” and “alcohol use during pregnancy”, missing values were up to 18% and a “missing category” was therefore created. The group “medication users with no ED” is the referent group for all analyses.</p><p>*Indicates p-value ≤ 0.001</p><p><sup>‡</sup>Indicates p-value ≤ 0.01.</p><p>Maternal sociodemographics, morbidities and mental health across the eating disorder subtype (n = 62,019)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0133045#t001fn008" target="_blank"><sup>†</sup></a>.</p

    Protein-protein interaction network build from proteins encoded in associated intervals.

    No full text
    <p>The colored, full circles represent proteins encoded in associated intervals (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0122501#pone.0122501.s002" target="_blank">S2 Table</a>). The smaller, grey circles represent interactors of indirect connections. Functionally, the DAPPLE-constructed diagram can be divided into two main groups: group “A” mostly involved in the regulation of gene expression and inflammation; and group “B” mostly involved in cell adhesion.</p

    List of SNPs with observed association p-value being less than 1.00E-05.

    No full text
    <p>Chromosomal position is specified in Build 36 (hg18). OR refers to odds ratio and 95%CI refers to 95% confidence interval. <i>TRIM36</i> refers to tripartite motif containing 36 gene. <i>ZBTB16</i> refers to zinc finger and BTB domain containing 16 gene.</p><p>List of SNPs with observed association p-value being less than 1.00E-05.</p
    corecore